Navigation Links
U.S. Scientists Map Genome of Advanced Prostate Cancer
Date:9/27/2011

TUESDAY, Sept. 27 (HealthDay News) -- A number of recurrent genetic errors common to advanced lethal prostate cancers have been identified by scientists who conducted the first complete genome mapping of these types of cancers.

The team also identified several instances of genetic "hypermutation," an excess of single-letter DNA errors that can give the cancers resistance to therapies commonly used to slow advanced prostate cancer, such as surgical castration and androgen-blocking drugs.

The study by researchers at the Fred Hutchinson Cancer Research Center and the University of Washington in Seattle was published in this week's online edition of the Proceedings of the National Academy of Sciences.

"The most interesting finding to come out of our DNA sequencing project was the discovery of three aggressive tumor types that had 10 times the number of mutations compared to the other advanced prostate cancers we studied," co-corresponding author Dr. Peter S. Nelson said in a research center news release.

"That was very surprising and unusual. We don't know the cause of these hypermutated tumors, but the frequency of the mutations suggests these tumors might evolve very rapidly to develop resistance to therapies," he added.

The discovery of these genetic mutations could help improve understanding of why some prostate cancers are so deadly, and could also lead to improved screening tests or treatments, Nelson suggested.

More information

The American Cancer Society has more about prostate cancer.

-- Robert Preidt

SOURCE: Fred Hutchinson Cancer Research Center, news release, Sept. 26, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Scientists ID More Genes Linked to Heart Disease
2. UCLA scientists find H1N1 flu virus prevalent in animals in Africa
3. Scientists Reconstruct the Movies in Our Minds
4. Scientists Discover Key Gene Mutation Behind Lou Gehrigs Disease
5. Scientists identify a key molecule that blocks abnormal blood vessel growth in tumors
6. NIH scientists find earliest known evidence of 1918 influenza pandemic
7. A*STAR scientists make headway for cancer treatment and cancer prevention with landmark discovery
8. To treat rare disease, NIH scientists repurpose FDA-approved drug
9. UT MD Anderson scientists discover secret life of chromatin
10. Scientists Use Stem Cells for Blood Self-Transfusion
11. Scripps Research scientists reveal how white blood cell promotes growth and spread of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Scientists Map Genome of Advanced Prostate Cancer
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... California (PRWEB) , ... May 26, 2016 , ... ... associated with discovery of thousands of defective respirators, according to court documents and ... the case of William and Becky Tyler v. American Optical Corporation, Case No. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through ... a partner for the Tamika Catchings Legacy Tour that will commemorate the ... in hardwood basketball surfaces in all forms and levels of the game, Connor Sports ...
(Date:5/26/2016)... PA (PRWEB) , ... May 26, 2016 , ... ... and one that has a significant negative impact on long-term patient survival, reports ... date. The results, published online this week in the Journal of Thoracic and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Israel , May 27, 2016 ... an innovative biopharmaceutical company focused on late-stage drug ... Dexcel Pharma of pivotal batches required ... and Drug Administration (FDA). This follows Kitov,s ... Phase III trial successfully met its primary efficacy ...
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
(Date:5/25/2016)... , May 25,2016 FDA ... near-infrared Cellvizio platform for urological and surgical applications ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... milestone in the US with the 12 th ... Drug Administration (FDA). This new FDA clearance covers ...
Breaking Medicine Technology: